{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T07:47:02Z","timestamp":1794988022278,"version":"4.9.1"},"reference-count":206,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIH","award":["RF1 NS113839; R01 NS075599"],"award-info":[{"award-number":["RF1 NS113839; R01 NS075599"]}]},{"DOI":"10.13039\/100018028","name":"Iowa City Veterans Affairs Medical Center","doi-asserted-by":"publisher","award":["I01 RX003523-01"],"award-info":[{"award-number":["I01 RX003523-01"]}],"id":[{"id":"10.13039\/100018028","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The neuropeptides calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase-activating polypeptide (PACAP) have emerged as mediators of migraine pathogenesis. Both are vasodilatory peptides that can cause migraine-like attacks when infused into people and migraine-like symptoms when injected into rodents. In this narrative review, we compare the similarities and differences between the peptides in both their clinical and preclinical migraine actions. A notable clinical difference is that PACAP, but not CGRP, causes premonitory-like symptoms in patients. Both peptides are found in distinct, but overlapping areas relevant to migraine, most notably with the prevalence of CGRP in trigeminal ganglia and PACAP in sphenopalatine ganglia. In rodents, the two peptides share activities, including vasodilation, neurogenic inflammation, and nociception. Most strikingly, CGRP and PACAP cause similar migraine-like symptoms in rodents that are manifested as light aversion and tactile allodynia. Yet, the peptides appear to act by independent mechanisms possibly by distinct intracellular signaling pathways. The complexity of these signaling pathways is magnified by the existence of multiple CGRP and PACAP receptors that may contribute to migraine pathogenesis. Based on these differences, we suggest PACAP and its receptors provide a rich set of targets to complement and augment the current CGRP-based migraine therapeutics.<\/jats:p>","DOI":"10.1186\/s10194-023-01569-2","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T06:25:20Z","timestamp":1680503120000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":100,"title":["Shared and independent roles of CGRP and PACAP in migraine pathophysiology"],"prefix":"10.1186","volume":"24","author":[{"given":"Adisa","family":"Kuburas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew F.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,3]]},"reference":[{"issue":"11","key":"1569_CR1","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/S1474-4422(18)30322-3","volume":"17","author":"GBDH Collaborators","year":"2018","unstructured":"Collaborators GBDH (2018) Global, regional, and national burden of migraine and tension-type headache, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17(11):954\u2013976","journal-title":"Lancet Neurol"},{"issue":"1","key":"1569_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2018) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38(1):1\u2013211","journal-title":"Cephalalgia"},{"issue":"3","key":"1569_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/WCO.0000000000000440","volume":"30","author":"C Ramon","year":"2017","unstructured":"Ramon C, Cernuda-Morollon E, Pascual J (2017) Calcitonin gene-related peptide in peripheral blood as a biomarker for migraine. Curr Opin Neurol 30(3):281\u2013286","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"1569_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/ana.410330109","volume":"33","author":"PJ Goadsby","year":"1993","unstructured":"Goadsby PJ, Edvinsson L (1993) The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 33(1):48\u201356","journal-title":"Ann Neurol"},{"issue":"2","key":"1569_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/ana.410280213","volume":"28","author":"PJ Goadsby","year":"1990","unstructured":"Goadsby PJ, Edvinsson L, Ekman R (1990) Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 28(2):183\u2013187","journal-title":"Ann Neurol"},{"issue":"3","key":"1569_CR6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/WCO.0000000000001053","volume":"35","author":"B Tesfay","year":"2022","unstructured":"Tesfay B et al (2022) Is calcitonin gene-related peptide a reliable biochemical marker of migraine? Curr Opin Neurol 35(3):343\u2013352","journal-title":"Curr Opin Neurol"},{"issue":"4","key":"1569_CR7","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/ana.20605","volume":"58","author":"JF Tvedskov","year":"2005","unstructured":"Tvedskov JF et al (2005) No increase of calcitonin gene-related peptide in jugular blood during migraine. Ann Neurol 58(4):561\u2013568","journal-title":"Ann Neurol"},{"issue":"1","key":"1569_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s10194-018-0883-x","volume":"19","author":"MJ Lee","year":"2018","unstructured":"Lee MJ et al (2018) Feasibility of serum CGRP measurement as a biomarker of chronic migraine: a critical reappraisal. J Headache Pain 19(1):53","journal-title":"J Headache Pain"},{"issue":"11","key":"1569_CR9","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/S1474-4422(14)70209-1","volume":"13","author":"DW Dodick","year":"2014","unstructured":"Dodick DW et al (2014) Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial. Lancet Neurol 13(11):1100\u20131107","journal-title":"Lancet Neurol"},{"issue":"9","key":"1569_CR10","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S1474-4422(14)70128-0","volume":"13","author":"DW Dodick","year":"2014","unstructured":"Dodick DW et al (2014) Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study. Lancet Neurol 13(9):885\u2013892","journal-title":"Lancet Neurol"},{"issue":"11","key":"1569_CR11","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(15)00245-8","volume":"14","author":"ME Bigal","year":"2015","unstructured":"Bigal ME et al (2015) Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study. Lancet Neurol 14(11):1091\u20131100","journal-title":"Lancet Neurol"},{"issue":"12","key":"1569_CR12","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.3390\/brainsci12121612","volume":"12","author":"JP Rissardo","year":"2022","unstructured":"Rissardo JP, Caprara ALF (2022) Gepants for acute and preventive migraine treatment: a narrative review. Brain Sci 12(12):1612","journal-title":"Brain Sci"},{"issue":"10210","key":"1569_CR13","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/S0140-6736(19)32504-8","volume":"394","author":"A Charles","year":"2019","unstructured":"Charles A, Pozo-Rosich P (2019) Targeting calcitonin gene-related peptide: a new era in migraine therapy. Lancet 394(10210):1765\u20131774","journal-title":"Lancet"},{"issue":"1","key":"1569_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3390\/cells12010143","volume":"12","author":"AR Pavelic","year":"2022","unstructured":"Pavelic AR et al (2022) Monoclonal antibodies against calcitonin gene-related peptide for migraine prophylaxis: a systematic review of real-world data. Cells 12(1):143","journal-title":"Cells"},{"issue":"6","key":"1569_CR15","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.3390\/jcm11061656","volume":"11","author":"D Moreno-Ajona","year":"2022","unstructured":"Moreno-Ajona D, Villar-Martinez MD, Goadsby PJ (2022) New generation gepants: migraine acute and preventive medications. J Clin Med 11(6):1656","journal-title":"J Clin Med"},{"issue":"Suppl 2","key":"1569_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/head.13084","volume":"57","author":"AF Russo","year":"2017","unstructured":"Russo AF (2017) Overview of neuropeptides: awakening the senses? Headache 57(Suppl 2):37\u201346","journal-title":"Headache"},{"issue":"Pt 3","key":"1569_CR17","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/brain\/awt369","volume":"137","author":"FM Amin","year":"2014","unstructured":"Amin FM et al (2014) Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38. Brain 137(Pt 3):779\u2013794","journal-title":"Brain"},{"issue":"Pt 1","key":"1569_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/brain\/awn307","volume":"132","author":"HW Schytz","year":"2009","unstructured":"Schytz HW et al (2009) PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain 132(Pt 1):16\u201325","journal-title":"Brain"},{"issue":"13","key":"1569_CR19","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1177\/0333102413483931","volume":"33","author":"B Tuka","year":"2013","unstructured":"Tuka B et al (2013) Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients. Cephalalgia 33(13):1085\u20131095","journal-title":"Cephalalgia"},{"issue":"5","key":"1569_CR20","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1210\/endo-129-5-2787","volume":"129","author":"A Arimura","year":"1991","unstructured":"Arimura A et al (1991) Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes. Endocrinology 129(5):2787\u20132789","journal-title":"Endocrinology"},{"issue":"6","key":"1569_CR21","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.peptides.2008.01.022","volume":"29","author":"S Bourgault","year":"2008","unstructured":"Bourgault S et al (2008) Novel stable PACAP analogs with potent activity towards the PAC1 receptor. Peptides 29(6):919\u2013932","journal-title":"Peptides"},{"issue":"12","key":"1569_CR22","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/acn3.113","volume":"1","author":"AS Zagami","year":"2014","unstructured":"Zagami AS, Edvinsson L, Goadsby PJ (2014) Pituitary adenylate cyclase activating polypeptide and migraine. Ann Clin Transl Neurol 1(12):1036\u20131040","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"1569_CR23","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s10194-017-0821-3","volume":"18","author":"H Ashina","year":"2017","unstructured":"Ashina H et al (2017) PACAP38 in human models of primary headaches. J Headache Pain 18(1):110","journal-title":"J Headache Pain"},{"issue":"2","key":"1569_CR24","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1177\/0333102416639517","volume":"37","author":"S Guo","year":"2017","unstructured":"Guo S et al (2017) Part II: Biochemical changes after pituitary adenylate cyclase-activating polypeptide-38 infusion in migraine patients. Cephalalgia 37(2):136\u2013147","journal-title":"Cephalalgia"},{"issue":"1","key":"1569_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/0333102419864507","volume":"40","author":"H Ghanizada","year":"2020","unstructured":"Ghanizada H et al (2020) PACAP27 induces migraine-like attacks in migraine patients. Cephalalgia 40(1):57\u201367","journal-title":"Cephalalgia"},{"key":"1569_CR26","doi-asserted-by":"crossref","unstructured":"Russo AF, Hay DL (2022) CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond. Physiol Rev 103(2):1565\u20131644","DOI":"10.1152\/physrev.00059.2021"},{"issue":"10","key":"1569_CR27","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.3390\/ph15101189","volume":"15","author":"CE Christensen","year":"2022","unstructured":"Christensen CE, Ashina M, Amin FM (2022) Calcitonin Gene-Related Peptide (CGRP) and Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in migraine pathogenesis. Pharmaceuticals (Basel) 15(10):1189","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"1569_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s10194-018-0852-4","volume":"19","author":"L Edvinsson","year":"2018","unstructured":"Edvinsson L et al (2018) PACAP and its role in primary headaches. J Headache Pain 19(1):21","journal-title":"J Headache Pain"},{"issue":"19","key":"1569_CR29","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1056\/NEJMra1915327","volume":"383","author":"M Ashina","year":"2020","unstructured":"Ashina M (2020) Migraine. N Engl J Med 383(19):1866\u20131876","journal-title":"N Engl J Med"},{"key":"1569_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105946","volume":"176","author":"S Guo","year":"2023","unstructured":"Guo S et al (2023) Role of PACAP in migraine: an alternative to CGRP? Neurobiol Dis 176:105946","journal-title":"Neurobiol Dis"},{"key":"1569_CR31","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1146\/annurev-pharmtox-010814-124701","volume":"55","author":"AF Russo","year":"2015","unstructured":"Russo AF (2015) Calcitonin gene-related peptide (CGRP): a new target for migraine. Annu Rev Pharmacol Toxicol 55:533\u2013552","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1569_CR32","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/164_2018_201","volume":"255","author":"L Edvinsson","year":"2019","unstructured":"Edvinsson L (2019) Role of CGRP in migraine. Handb Exp Pharmacol 255:121\u2013130","journal-title":"Handb Exp Pharmacol"},{"key":"1569_CR33","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/164_2018_128","volume":"255","author":"H Ashina","year":"2019","unstructured":"Ashina H, Schytz HW, Ashina M (2019) CGRP in human models of migraine. Handb Exp Pharmacol 255:109\u2013120","journal-title":"Handb Exp Pharmacol"},{"issue":"1","key":"1569_CR34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1046\/j.1468-2982.2002.00310.x","volume":"22","author":"LH Lassen","year":"2002","unstructured":"Lassen LH et al (2002) CGRP may play a causative role in migraine. Cephalalgia 22(1):54\u201361","journal-title":"Cephalalgia"},{"issue":"4","key":"1569_CR35","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/ana.22292","volume":"69","author":"MS Asghar","year":"2011","unstructured":"Asghar MS et al (2011) Evidence for a vascular factor in migraine. Ann Neurol 69(4):635\u2013645","journal-title":"Ann Neurol"},{"issue":"10","key":"1569_CR36","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1177\/0333102410368444","volume":"30","author":"JM Hansen","year":"2010","unstructured":"Hansen JM et al (2010) Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura. Cephalalgia 30(10):1179\u20131186","journal-title":"Cephalalgia"},{"issue":"2","key":"1569_CR37","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1177\/0333102416639512","volume":"37","author":"S Guo","year":"2017","unstructured":"Guo S et al (2017) Calcitonin gene-related peptide induced migraine attacks in patients with and without familial aggregation of migraine. Cephalalgia 37(2):114\u2013124","journal-title":"Cephalalgia"},{"issue":"12","key":"1569_CR38","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1097\/j.pain.0000000000000702","volume":"157","author":"S Guo","year":"2016","unstructured":"Guo S et al (2016) Premonitory and nonheadache symptoms induced by CGRP and PACAP38 in patients with migraine. Pain 157(12):2773\u20132781","journal-title":"Pain"},{"issue":"1","key":"1569_CR39","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s10194-018-0927-2","volume":"19","author":"CE Christensen","year":"2018","unstructured":"Christensen CE et al (2018) Migraine induction with calcitonin gene-related peptide in patients from erenumab trials. J Headache Pain 19(1):105","journal-title":"J Headache Pain"},{"issue":"6","key":"1569_CR40","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/ana.26072","volume":"89","author":"H Ghanizada","year":"2021","unstructured":"Ghanizada H et al (2021) Amylin analog pramlintide induces migraine-like attacks in patients. Ann Neurol 89(6):1157\u20131171","journal-title":"Ann Neurol"},{"issue":"2","key":"1569_CR41","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1177\/0333102416639516","volume":"37","author":"S Guo","year":"2017","unstructured":"Guo S et al (2017) Part I: Pituitary adenylate cyclase-activating polypeptide-38 induced migraine-like attacks in patients with and without familial aggregation of migraine. Cephalalgia 37(2):125\u2013135","journal-title":"Cephalalgia"},{"issue":"6","key":"1569_CR42","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1177\/0333102420975395","volume":"41","author":"NKF Wienholtz","year":"2021","unstructured":"Wienholtz NKF et al (2021) Early treatment with sumatriptan prevents PACAP38-induced migraine: a randomised clinical trial. Cephalalgia 41(6):731\u2013748","journal-title":"Cephalalgia"},{"issue":"4","key":"1569_CR43","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/head.13747","volume":"60","author":"K Falkenberg","year":"2020","unstructured":"Falkenberg K et al (2020) Sumatriptan does not antagonize cgrp-induced symptoms in healthy volunteers. Headache 60(4):665\u2013676","journal-title":"Headache"},{"issue":"3","key":"1569_CR44","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1468-2982.2007.01497.x","volume":"28","author":"A Rahmann","year":"2008","unstructured":"Rahmann A et al (2008) Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine. Cephalalgia 28(3):226\u2013236","journal-title":"Cephalalgia"},{"issue":"8","key":"1569_CR45","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.18543","volume":"4","author":"L Pellesi","year":"2021","unstructured":"Pellesi L et al (2021) Effect of vasoactive intestinal polypeptide on development of migraine headaches: a randomized clinical trial. JAMA Netw Open 4(8):e2118543","journal-title":"JAMA Netw Open"},{"issue":"20","key":"1569_CR46","doi-asserted-by":"publisher","first-page":"e2488","DOI":"10.1212\/WNL.0000000000011930","volume":"96","author":"H Ghanizada","year":"2021","unstructured":"Ghanizada H et al (2021) Effect of adrenomedullin on migraine-like attacks in patients with migraine: a randomized crossover study. Neurology 96(20):e2488\u2013e2499","journal-title":"Neurology"},{"issue":"4","key":"1569_CR47","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1526-4610.1987.hed2704180.x","volume":"27","author":"F Sicuteri","year":"1987","unstructured":"Sicuteri F et al (1987) Unmasking latent dysnociception in healthy subjects. Headache 27(4):180\u2013185","journal-title":"Headache"},{"issue":"1","key":"1569_CR48","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1468-1331.1994.tb00053.x","volume":"1","author":"LL Thomsen","year":"1994","unstructured":"Thomsen LL et al (1994) A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks. Eur J Neurol 1(1):73\u201380","journal-title":"Eur J Neurol"},{"issue":"7","key":"1569_CR49","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1046\/j.1468-2982.1999.019007660.x","volume":"19","author":"I Christiansen","year":"1999","unstructured":"Christiansen I et al (1999) Glyceryl trinitrate induces attacks of migraine without aura in sufferers of migraine with aura. Cephalalgia 19(7):660\u20137 discussion 626","journal-title":"Cephalalgia"},{"issue":"3","key":"1569_CR50","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.pain.2004.05.007","volume":"110","author":"KS Afridi","year":"2004","unstructured":"Afridi KS, Kaube H, Goadsby JP (2004) Glyceryl trinitrate triggers premonitory symptoms in migraineurs. Pain 110(3):675\u2013680","journal-title":"Pain"},{"issue":"2","key":"1569_CR51","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1468-2982.2004.00639.x","volume":"24","author":"G Sances","year":"2004","unstructured":"Sances G et al (2004) Reliability of the nitroglycerin provocative test in the diagnosis of neurovascular headaches. Cephalalgia 24(2):110\u2013119","journal-title":"Cephalalgia"},{"issue":"Pt 1","key":"1569_CR52","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/brain\/awg009","volume":"126","author":"C Kruuse","year":"2003","unstructured":"Kruuse C et al (2003) Migraine can be induced by sildenafil without changes in middle cerebral artery diameter. Brain 126(Pt 1):241\u2013247","journal-title":"Brain"},{"issue":"8","key":"1569_CR53","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/j.1468-2982.2006.01137.x","volume":"26","author":"C Kruuse","year":"2006","unstructured":"Kruuse C et al (2006) Dipyridamole may induce migraine in patients with migraine without aura. Cephalalgia 26(8):925\u2013933","journal-title":"Cephalalgia"},{"issue":"Pt 11","key":"1569_CR54","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1093\/brain\/awu244","volume":"137","author":"S Guo","year":"2014","unstructured":"Guo S, Olesen J, Ashina M (2014) Phosphodiesterase 3 inhibitor cilostazol induces migraine-like attacks via cyclic AMP increase. Brain 137(Pt 11):2951\u20132959","journal-title":"Brain"},{"issue":"9","key":"1569_CR55","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1093\/brain\/awz199","volume":"142","author":"MA Al-Karagholi","year":"2019","unstructured":"Al-Karagholi MA et al (2019) Opening of ATP-sensitive potassium channels causes migraine attacks: a new target for the treatment of migraine. Brain 142(9):2644\u20132654","journal-title":"Brain"},{"issue":"8","key":"1569_CR56","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1093\/brain\/awab136","volume":"144","author":"MA Al-Karagholi","year":"2021","unstructured":"Al-Karagholi MA et al (2021) Opening of ATP sensitive potassium channels causes migraine attacks with aura. Brain 144(8):2322\u20132332","journal-title":"Brain"},{"issue":"11","key":"1569_CR57","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1097\/00001756-199507310-00003","volume":"6","author":"LH Lassen","year":"1995","unstructured":"Lassen LH, Thomsen LL, Olesen J (1995) Histamine induces migraine via the H1-receptor. Support for the NO hypothesis of migraine. Neuroreport 6(11):1475\u20139","journal-title":"Neuroreport"},{"issue":"11","key":"1569_CR58","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1177\/0333102412451360","volume":"32","author":"M Antonova","year":"2012","unstructured":"Antonova M et al (2012) Prostaglandin E(2) induces immediate migraine-like attack in migraine patients without aura. Cephalalgia 32(11):822\u2013833","journal-title":"Cephalalgia"},{"issue":"2","key":"1569_CR59","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1468-2982.2009.01923.x","volume":"30","author":"T Wienecke","year":"2010","unstructured":"Wienecke T, Olesen J, Ashina M (2010) Prostaglandin I2 (epoprostenol) triggers migraine-like attacks in migraineurs. Cephalalgia 30(2):179\u2013190","journal-title":"Cephalalgia"},{"issue":"11","key":"1569_CR60","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1177\/0333102420937655","volume":"40","author":"L Pellesi","year":"2020","unstructured":"Pellesi L et al (2020) Two-hour infusion of vasoactive intestinal polypeptide induces delayed headache and extracranial vasodilation in healthy volunteers. Cephalalgia 40(11):1212\u20131223","journal-title":"Cephalalgia"},{"issue":"3","key":"1569_CR61","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10194-008-0036-8","volume":"9","author":"LH Lassen","year":"2008","unstructured":"Lassen LH et al (2008) Involvement of calcitonin gene-related peptide in migraine: regional cerebral blood flow and blood flow velocity in migraine patients. J Headache Pain 9(3):151\u2013157","journal-title":"J Headache Pain"},{"issue":"17","key":"1569_CR62","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1212\/WNL.0b013e3181f9626a","volume":"75","author":"MS Asghar","year":"2010","unstructured":"Asghar MS et al (2010) Dilation by CGRP of middle meningeal artery and reversal by sumatriptan in normal volunteers. Neurology 75(17):1520\u20131526","journal-title":"Neurology"},{"issue":"2","key":"1569_CR63","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1177\/0333102411431333","volume":"32","author":"FM Amin","year":"2012","unstructured":"Amin FM et al (2012) Headache and prolonged dilatation of the middle meningeal artery by PACAP38 in healthy volunteers. Cephalalgia 32(2):140\u2013149","journal-title":"Cephalalgia"},{"issue":"Suppl 1","key":"1569_CR64","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/head.13300","volume":"58","author":"DW Dodick","year":"2018","unstructured":"Dodick DW (2018) A phase-by-phase review of migraine pathophysiology. Headache 58(Suppl 1):4\u201316","journal-title":"Headache"},{"issue":"2","key":"1569_CR65","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/head.12026","volume":"53","author":"A Charles","year":"2013","unstructured":"Charles A (2013) The evolution of a migraine attack - a review of recent evidence. Headache 53(2):413\u2013419","journal-title":"Headache"},{"issue":"2","key":"1569_CR66","first-page":"690","volume":"267","author":"WA Banks","year":"1993","unstructured":"Banks WA et al (1993) Passage of pituitary adenylate cyclase activating polypeptide1-27 and pituitary adenylate cyclase activating polypeptide1-38 across the blood-brain barrier. J Pharmacol Exp Ther 267(2):690\u2013696","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"1569_CR67","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/j.1526-4610.2007.00776.x","volume":"47","author":"M Denuelle","year":"2007","unstructured":"Denuelle M et al (2007) Hypothalamic activation in spontaneous migraine attacks. Headache 47(10):1418\u20131426","journal-title":"Headache"},{"issue":"Pt 7","key":"1569_CR68","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1093\/brain\/aww097","volume":"139","author":"LH Schulte","year":"2016","unstructured":"Schulte LH, May A (2016) The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks. Brain 139(Pt 7):1987\u20131993","journal-title":"Brain"},{"issue":"1","key":"1569_CR69","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s10194-022-01518-5","volume":"23","author":"C Gollion","year":"2022","unstructured":"Gollion C et al (2022) The premonitory phase of migraine is due to hypothalamic dysfunction: revisiting the evidence. J Headache Pain 23(1):158","journal-title":"J Headache Pain"},{"issue":"3","key":"1569_CR70","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1124\/pr.109.001370","volume":"61","author":"D Vaudry","year":"2009","unstructured":"Vaudry D et al (2009) Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol Rev 61(3):283\u2013357","journal-title":"Pharmacol Rev"},{"issue":"1","key":"1569_CR71","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s10194-017-0800-8","volume":"18","author":"MA Al-Karagholi","year":"2017","unstructured":"Al-Karagholi MA et al (2017) The K(ATP) channel in migraine pathophysiology: a novel therapeutic target for migraine. J Headache Pain 18(1):90","journal-title":"J Headache Pain"},{"key":"1569_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.652136","volume":"12","author":"H Coskun","year":"2021","unstructured":"Coskun H et al (2021) The Effect of K (ATP) CHANNEL Blocker Glibenclamide on CGRP-induced headache and hemodynamic in healthy volunteers. Front Physiol 12:652136","journal-title":"Front Physiol"},{"issue":"9","key":"1569_CR73","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1177\/03331024221080574","volume":"42","author":"L Kokoti","year":"2022","unstructured":"Kokoti L et al (2022) Effect of K(ATP) channel blocker glibenclamide on PACAP38-induced headache and hemodynamic. Cephalalgia 42(9):846\u2013858","journal-title":"Cephalalgia"},{"issue":"10","key":"1569_CR74","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1177\/0333102420949863","volume":"40","author":"MA Al-Karagholi","year":"2020","unstructured":"Al-Karagholi MA et al (2020) Effect of K(ATP) channel blocker glibenclamide on levcromakalim-induced headache. Cephalalgia 40(10):1045\u20131054","journal-title":"Cephalalgia"},{"issue":"3","key":"1569_CR75","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1177\/0333102417728873","volume":"39","author":"K Warfvinge","year":"2019","unstructured":"Warfvinge K, Edvinsson L (2019) Distribution of CGRP and CGRP receptor components in the rat brain. Cephalalgia 39(3):342\u2013353","journal-title":"Cephalalgia"},{"issue":"6","key":"1569_CR76","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1177\/0333102419893962","volume":"40","author":"K Warfvinge","year":"2020","unstructured":"Warfvinge K, Edvinsson L (2020) Cellular distribution of PACAP-38 and PACAP receptors in the rat brain: relation to migraine activated regions. Cephalalgia 40(6):527\u2013542","journal-title":"Cephalalgia"},{"issue":"5","key":"1569_CR77","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1097\/00004647-200205000-00014","volume":"22","author":"KR Oliver","year":"2002","unstructured":"Oliver KR et al (2002) Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature. J Cereb Blood Flow Metab 22(5):620\u2013629","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"1569_CR78","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/00001756-200203250-00030","volume":"13","author":"M Knutsson","year":"2002","unstructured":"Knutsson M, Edvinsson L (2002) Distribution of mRNA for VIP and PACAP receptors in human cerebral arteries and cranial ganglia. NeuroReport 13(4):507\u2013509","journal-title":"NeuroReport"},{"issue":"2","key":"1569_CR79","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/0333102410375624","volume":"31","author":"KY Chan","year":"2011","unstructured":"Chan KY et al (2011) Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery. Cephalalgia 31(2):181\u2013189","journal-title":"Cephalalgia"},{"issue":"13","key":"1569_CR80","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1177\/0333102418771350","volume":"39","author":"D Levy","year":"2019","unstructured":"Levy D, Labastida-Ramirez A, MaassenVanDenBrink A (2019) Current understanding of meningeal and cerebral vascular function underlying migraine headache. Cephalalgia 39(13):1606\u20131622","journal-title":"Cephalalgia"},{"issue":"4","key":"1569_CR81","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/0196-9781(85)90178-0","volume":"6","author":"G Skofitsch","year":"1985","unstructured":"Skofitsch G, Jacobowitz DM (1985) Calcitonin gene-related peptide: detailed immunohistochemical distribution in the central nervous system. Peptides 6(4):721\u2013745","journal-title":"Peptides"},{"issue":"1","key":"1569_CR82","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1073\/pnas.82.1.248","volume":"82","author":"FA Tschopp","year":"1985","unstructured":"Tschopp FA et al (1985) Calcitonin gene-related peptide and its binding sites in the human central nervous system and pituitary. Proc Natl Acad Sci U S A 82(1):248\u2013252","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1569_CR83","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/(SICI)1096-9861(19960805)371:4<567::AID-CNE6>3.0.CO;2-2","volume":"371","author":"H Hashimoto","year":"1996","unstructured":"Hashimoto H et al (1996) Distribution of the mRNA for a pituitary adenylate cyclase-activating polypeptide receptor in the rat brain: an in situ hybridization study. J Comp Neurol 371(4):567\u2013577","journal-title":"J Comp Neurol"},{"issue":"1","key":"1569_CR84","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s10194-016-0664-3","volume":"17","author":"A Steinberg","year":"2016","unstructured":"Steinberg A et al (2016) Expression of messenger molecules and receptors in rat and human sphenopalatine ganglion indicating therapeutic targets. J Headache Pain 17(1):78","journal-title":"J Headache Pain"},{"issue":"7","key":"1569_CR85","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1177\/0333102418821621","volume":"39","author":"K Hensley","year":"2019","unstructured":"Hensley K et al (2019) PAC1 receptor mRNA and protein distribution in rat and human trigeminal and sphenopalatine ganglia, spinal trigeminal nucleus and in dura mater. Cephalalgia 39(7):827\u2013840","journal-title":"Cephalalgia"},{"key":"1569_CR86","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.brainres.2011.11.058","volume":"1435","author":"A Csati","year":"2012","unstructured":"Csati A et al (2012) Calcitonin gene-related peptide and its receptor components in the human sphenopalatine ganglion \u2013 interaction with the sensory system. Brain Res 1435:29\u201339","journal-title":"Brain Res"},{"issue":"3","key":"1569_CR87","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/j.1526-4610.2011.01843.x","volume":"51","author":"JJ Ivanusic","year":"2011","unstructured":"Ivanusic JJ et al (2011) 5-HT(1D) receptor immunoreactivity in the sphenopalatine ganglion: implications for the efficacy of triptans in the treatment of autonomic signs associated with cluster headache. Headache 51(3):392\u2013402","journal-title":"Headache"},{"issue":"1","key":"1569_CR88","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0006-8993(97)00737-3","volume":"767","author":"T Kozicz","year":"1997","unstructured":"Kozicz T, Vigh S, Arimura A (1997) Axon terminals containing PACAP- and VIP-immunoreactivity form synapses with CRF-immunoreactive neurons in the dorsolateral division of the bed nucleus of the stria terminalis in the rat. Brain Res 767(1):109\u2013119","journal-title":"Brain Res"},{"issue":"2","key":"1569_CR89","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0006-8993(88)90395-2","volume":"463","author":"L Kruger","year":"1988","unstructured":"Kruger L et al (1988) Calcitonin gene-related peptide (CGRP) in the rat central nervous system: patterns of immunoreactivity and receptor binding sites. Brain Res 463(2):223\u2013244","journal-title":"Brain Res"},{"issue":"5\u20136","key":"1569_CR90","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3109\/08990228909144689","volume":"6","author":"F Conti","year":"1989","unstructured":"Conti F, Sternini C (1989) Calcitonin gene-related peptide (CGRP)-positive neurons and fibers in the cat periaqueductal grey matter. Somatosens Mot Res 6(5\u20136):497\u2013511","journal-title":"Somatosens Mot Res"},{"issue":"1","key":"1569_CR91","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/cne.23828","volume":"524","author":"S Eftekhari","year":"2016","unstructured":"Eftekhari S et al (2016) Localization of CGRP receptor components and receptor binding sites in rhesus monkey brainstem: a detailed study using in situ hybridization, immunofluorescence, and autoradiography. J Comp Neurol 524(1):90\u2013118","journal-title":"J Comp Neurol"},{"key":"1569_CR92","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.npep.2018.12.002","volume":"74","author":"A Castorina","year":"2019","unstructured":"Castorina A et al (2019) PACAP and VIP expression in the periaqueductal grey of the rat following sciatic nerve constriction injury. Neuropeptides 74:60\u201369","journal-title":"Neuropeptides"},{"issue":"2","key":"1569_CR93","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1046\/j.1468-2982.2002.00324.x","volume":"22","author":"R Uddman","year":"2002","unstructured":"Uddman R et al (2002) Neuropeptide expression in the human trigeminal nucleus caudalis and in the cervical spinal cord C1 and C2. Cephalalgia 22(2):112\u2013116","journal-title":"Cephalalgia"},{"issue":"3","key":"1569_CR94","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1002\/cne.21607","volume":"507","author":"JK Lennerz","year":"2008","unstructured":"Lennerz JK et al (2008) Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. J Comp Neurol 507(3):1277\u20131299","journal-title":"J Comp Neurol"},{"key":"1569_CR95","doi-asserted-by":"publisher","first-page":"174480691882045","DOI":"10.1177\/1744806918820452","volume":"15","author":"Q Zhang","year":"2019","unstructured":"Zhang Q et al (2019) Dynamic changes in CGRP, PACAP, and PACAP receptors in the trigeminovascular system of a novel repetitive electrical stimulation rat model: Relevant to migraine. Mol Pain 15:1744806918820452","journal-title":"Mol Pain"},{"issue":"4","key":"1569_CR96","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/cne.10418","volume":"453","author":"J Hannibal","year":"2002","unstructured":"Hannibal J (2002) Pituitary adenylate cyclase-activating peptide in the rat central nervous system: an immunohistochemical and in situ hybridization study. J Comp Neurol 453(4):389\u2013417","journal-title":"J Comp Neurol"},{"issue":"5","key":"1569_CR97","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S0149-7634(96)00023-1","volume":"21","author":"D van Rossum","year":"1997","unstructured":"van Rossum D, Hanisch UK, Quirion R (1997) Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neurosci Biobehav Rev 21(5):649\u2013678","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"1569_CR98","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0306-4522(94)90025-6","volume":"63","author":"H Mulder","year":"1994","unstructured":"Mulder H et al (1994) Pituitary adenylate cyclase activating polypeptide expression in sensory neurons. Neuroscience 63(1):307\u2013312","journal-title":"Neuroscience"},{"key":"1569_CR99","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.brainres.2014.11.031","volume":"1600","author":"S Eftekhari","year":"2015","unstructured":"Eftekhari S et al (2015) Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier. Brain Res 1600:93\u2013109","journal-title":"Brain Res"},{"issue":"2","key":"1569_CR100","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0169-328X(02)00329-7","volume":"104","author":"P Chaudhary","year":"2002","unstructured":"Chaudhary P, Baumann TK (2002) Expression of VPAC2 receptor and PAC1 receptor splice variants in the trigeminal ganglion of the adult rat. Brain Res Mol Brain Res 104(2):137\u2013142","journal-title":"Brain Res Mol Brain Res"},{"issue":"1","key":"1569_CR101","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0306-4522(88)90018-8","volume":"25","author":"PK Mulderry","year":"1988","unstructured":"Mulderry PK et al (1988) Differential expression of alpha-CGRP and beta-CGRP by primary sensory neurons and enteric autonomic neurons of the rat. Neuroscience 25(1):195\u2013205","journal-title":"Neuroscience"},{"issue":"3","key":"1569_CR102","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/cne.20669","volume":"490","author":"GS Cottrell","year":"2005","unstructured":"Cottrell GS et al (2005) Localization of calcitonin receptor-like receptor and receptor activity modifying protein 1 in enteric neurons, dorsal root ganglia, and the spinal cord of the rat. J Comp Neurol 490(3):239\u2013255","journal-title":"J Comp Neurol"},{"issue":"4","key":"1569_CR103","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.mcn.2003.12.004","volume":"25","author":"KM Nielsen","year":"2004","unstructured":"Nielsen KM et al (2004) PACAP promotes sensory neuron differentiation: blockade by neurotrophic factors. Mol Cell Neurosci 25(4):629\u2013641","journal-title":"Mol Cell Neurosci"},{"issue":"2","key":"1569_CR104","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0167-0115(91)90478-Y","volume":"35","author":"A Cauvin","year":"1991","unstructured":"Cauvin A et al (1991) Properties and distribution of receptors for pituitary adenylate cyclase activating peptide (PACAP) in rat brain and spinal cord. Regul Pept 35(2):161\u2013173","journal-title":"Regul Pept"},{"issue":"6","key":"1569_CR105","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/jcbfm.1987.126","volume":"7","author":"L Edvinsson","year":"1987","unstructured":"Edvinsson L et al (1987) Calcitonin gene-related peptide and cerebral blood vessels: distribution and vasomotor effects. J Cereb Blood Flow Metab 7(6):720\u2013728","journal-title":"J Cereb Blood Flow Metab"},{"key":"1569_CR106","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.860037","volume":"13","author":"TA Rees","year":"2022","unstructured":"Rees TA et al (2022) CGRP and the calcitonin receptor are co-expressed in mouse, rat and human trigeminal ganglia neurons. Front Physiol 13:860037","journal-title":"Front Physiol"},{"issue":"2","key":"1569_CR107","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.npep.2014.01.004","volume":"48","author":"I Jansen-Olesen","year":"2014","unstructured":"Jansen-Olesen I et al (2014) PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor. Neuropeptides 48(2):53\u201364","journal-title":"Neuropeptides"},{"issue":"2\u20133","key":"1569_CR108","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0165-1838(99)00024-7","volume":"76","author":"J Tajti","year":"1999","unstructured":"Tajti J et al (1999) Messenger molecules and receptor mRNA in the human trigeminal ganglion. J Auton Nerv Syst 76(2\u20133):176\u2013183","journal-title":"J Auton Nerv Syst"},{"issue":"1","key":"1569_CR109","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s10194-017-0822-2","volume":"19","author":"I Jansen-Olesen","year":"2018","unstructured":"Jansen-Olesen I, Hougaard Pedersen S (2018) PACAP and its receptors in cranial arteries and mast cells. J Headache Pain 19(1):16","journal-title":"J Headache Pain"},{"key":"1569_CR110","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.neuroscience.2018.10.004","volume":"393","author":"SD Frederiksen","year":"2018","unstructured":"Frederiksen SD et al (2018) Expression of pituitary adenylate cyclase-activating peptide, calcitonin gene-related peptide and headache targets in the trigeminal ganglia of rats and humans. Neuroscience 393:319\u2013332","journal-title":"Neuroscience"},{"key":"1569_CR111","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.neuroscience.2011.10.055","volume":"202","author":"A Csati","year":"2012","unstructured":"Csati A et al (2012) Distribution of vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, nitric oxide synthase, and their receptors in human and rat sphenopalatine ganglion. Neuroscience 202:158\u2013168","journal-title":"Neuroscience"},{"issue":"2","key":"1569_CR112","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.neuroscience.2010.05.016","volume":"169","author":"S Eftekhari","year":"2010","unstructured":"Eftekhari S et al (2010) Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion. Neuroscience 169(2):683\u2013696","journal-title":"Neuroscience"},{"issue":"2","key":"1569_CR113","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0006-8993(99)01260-3","volume":"826","author":"R Uddman","year":"1999","unstructured":"Uddman R et al (1999) Neuronal messengers and peptide receptors in the human sphenopalatine and otic ganglia. Brain Res 826(2):193\u2013199","journal-title":"Brain Res"},{"key":"1569_CR114","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000434661","volume":"29","author":"J Schoenen","year":"2015","unstructured":"Schoenen J (2015) Sphenopalatine ganglion stimulation in neurovascular headaches. Prog Neurol Surg 29:106\u2013116","journal-title":"Prog Neurol Surg"},{"issue":"8","key":"1569_CR115","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/j.1526-4610.2009.01501.x","volume":"49","author":"S Akerman","year":"2009","unstructured":"Akerman S et al (2009) Oxygen inhibits neuronal activation in the trigeminocervical complex after stimulation of trigeminal autonomic reflex, but not during direct dural activation of trigeminal afferents. Headache 49(8):1131\u20131143","journal-title":"Headache"},{"issue":"Pt 12","key":"1569_CR116","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1093\/brain\/aws249","volume":"135","author":"S Akerman","year":"2012","unstructured":"Akerman S et al (2012) A translational in vivo model of trigeminal autonomic cephalalgias: therapeutic characterization. Brain 135(Pt 12):3664\u20133675","journal-title":"Brain"},{"issue":"2","key":"1569_CR117","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1124\/jpet.113.206458","volume":"347","author":"ED Hostetler","year":"2013","unstructured":"Hostetler ED et al (2013) In vivo quantification of calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using the positron emission tomography tracer [11C]MK-4232. J Pharmacol Exp Ther 347(2):478\u2013486","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"1569_CR118","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.nurt.2010.02.003","volume":"7","author":"HW Schytz","year":"2010","unstructured":"Schytz HW, Olesen J, Ashina M (2010) The PACAP receptor: a novel target for migraine treatment. Neurotherapeutics 7(2):191\u2013196","journal-title":"Neurotherapeutics"},{"issue":"2","key":"1569_CR119","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.peptides.2011.12.019","volume":"33","author":"B Tuka","year":"2012","unstructured":"Tuka B et al (2012) Peripheral and central alterations of pituitary adenylate cyclase activating polypeptide-like immunoreactivity in the rat in response to activation of the trigeminovascular system. Peptides 33(2):307\u2013316","journal-title":"Peptides"},{"issue":"1","key":"1569_CR120","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0006-8993(92)90430-H","volume":"575","author":"Y Masuo","year":"1992","unstructured":"Masuo Y et al (1992) Binding sites for pituitary adenylate cyclase activating polypeptide (PACAP): comparison with vasoactive intestinal polypeptide (VIP) binding site localization in rat brain sections. Brain Res 575(1):113\u2013123","journal-title":"Brain Res"},{"key":"1569_CR121","doi-asserted-by":"crossref","unstructured":"Tajti J, Uddman R, Edvinsson L (2001) Neuropeptide localization in the \u201cmigraine generator\u201d region of the human brainstem. Cephalalgia 21(2):96\u2013101","DOI":"10.1046\/j.1468-2982.2001.00140.x"},{"issue":"2\u20133","key":"1569_CR122","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0014-2999(96)00359-7","volume":"311","author":"M Narita","year":"1996","unstructured":"Narita M et al (1996) Hyperalgesia induced by pituitary adenylate cyclase-activating polypeptide in the mouse spinal cord. Eur J Pharmacol 311(2\u20133):121\u2013126","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1569_CR123","first-page":"269","volume":"52","author":"D Vaudry","year":"2000","unstructured":"Vaudry D et al (2000) Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol Rev 52(2):269\u2013324","journal-title":"Pharmacol Rev"},{"issue":"1\u20132","key":"1569_CR124","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S0169-328X(01)00153-X","volume":"92","author":"C Otto","year":"2001","unstructured":"Otto C et al (2001) Altered emotional behavior in PACAP-type-I-receptor-deficient mice. Brain Res Mol Brain Res 92(1\u20132):78\u201384","journal-title":"Brain Res Mol Brain Res"},{"key":"1569_CR125","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3389\/fnbeh.2012.00058","volume":"6","author":"S Hattori","year":"2012","unstructured":"Hattori S et al (2012) Comprehensive behavioral analysis of pituitary adenylate cyclase-activating polypeptide (PACAP) knockout mice. Front Behav Neurosci 6:58","journal-title":"Front Behav Neurosci"},{"issue":"7335","key":"1569_CR126","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nature09856","volume":"470","author":"KJ Ressler","year":"2011","unstructured":"Ressler KJ et al (2011) Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature 470(7335):492\u2013497","journal-title":"Nature"},{"issue":"6","key":"1569_CR127","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.psyneuen.2008.12.013","volume":"34","author":"SE Hammack","year":"2009","unstructured":"Hammack SE et al (2009) Chronic stress increases pituitary adenylate cyclase-activating peptide (PACAP) and brain-derived neurotrophic factor (BDNF) mRNA expression in the bed nucleus of the stria terminalis (BNST): roles for PACAP in anxiety-like behavior. Psychoneuroendocrinology 34(6):833\u2013843","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"1569_CR128","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s12031-010-9364-7","volume":"42","author":"SE Hammack","year":"2010","unstructured":"Hammack SE et al (2010) Roles for pituitary adenylate cyclase-activating peptide (PACAP) expression and signaling in the bed nucleus of the stria terminalis (BNST) in mediating the behavioral consequences of chronic stress. J Mol Neurosci 42(3):327\u2013340","journal-title":"J Mol Neurosci"},{"key":"1569_CR129","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1196\/annals.1317.038","volume":"1070","author":"H Hashimoto","year":"2006","unstructured":"Hashimoto H, Shintani N, Baba A (2006) New insights into the central PACAPergic system from the phenotypes in PACAP- and PACAP receptor-knockout mice. Ann N Y Acad Sci 1070:75\u201389","journal-title":"Ann N Y Acad Sci"},{"key":"1569_CR130","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3389\/fncel.2018.00233","volume":"12","author":"BN Mason","year":"2018","unstructured":"Mason BN, Russo AF (2018) Vascular contributions to migraine: time to revisit? Front Cell Neurosci 12:233","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"1569_CR131","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.npep.2013.10.010","volume":"47","author":"EA Kaiser","year":"2013","unstructured":"Kaiser EA, Russo AF (2013) CGRP and migraine: could PACAP play a role too? Neuropeptides 47(6):451\u2013461","journal-title":"Neuropeptides"},{"issue":"12","key":"1569_CR132","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nrneurol.2017.137","volume":"13","author":"M Ashina","year":"2017","unstructured":"Ashina M et al (2017) Human models of migraine - short-term pain for long-term gain. Nat Rev Neurol 13(12):713\u2013724","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"1569_CR133","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1097\/00004647-200008000-00006","volume":"20","author":"J Fahrenkrug","year":"2000","unstructured":"Fahrenkrug J et al (2000) Immunohistochemical localization of the VIP1 receptor (VPAC1R) in rat cerebral blood vessels: relation to PACAP and VIP containing nerves. J Cereb Blood Flow Metab 20(8):1205\u20131214","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"1569_CR134","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.npep.2012.12.005","volume":"47","author":"A Erdling","year":"2013","unstructured":"Erdling A et al (2013) VIP\/PACAP receptors in cerebral arteries of rat: characterization, localization and relation to intracellular calcium. Neuropeptides 47(2):85\u201392","journal-title":"Neuropeptides"},{"issue":"4","key":"1569_CR135","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1177\/0333102412439354","volume":"32","author":"M Baun","year":"2012","unstructured":"Baun M et al (2012) Dural mast cell degranulation is a putative mechanism for headache induced by PACAP-38. Cephalalgia 32(4):337\u2013345","journal-title":"Cephalalgia"},{"issue":"1","key":"1569_CR136","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.brainresrev.2004.11.006","volume":"49","author":"TC Theoharides","year":"2005","unstructured":"Theoharides TC et al (2005) The role of mast cells in migraine pathophysiology. Brain Res Brain Res Rev 49(1):65\u201376","journal-title":"Brain Res Brain Res Rev"},{"issue":"12","key":"1569_CR137","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1097\/00001756-199808240-00027","volume":"9","author":"Y Zhang","year":"1998","unstructured":"Zhang Y et al (1998) Pituitary adenylate cyclase-activating peptide is upregulated in sensory neurons by inflammation. NeuroReport 9(12):2833\u20132836","journal-title":"NeuroReport"},{"issue":"9","key":"1569_CR138","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.peptides.2007.07.001","volume":"28","author":"Z Helyes","year":"2007","unstructured":"Helyes Z et al (2007) Inhibitory effect of PACAP-38 on acute neurogenic and non-neurogenic inflammatory processes in the rat. Peptides 28(9):1847\u20131855","journal-title":"Peptides"},{"issue":"1","key":"1569_CR139","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.neuroscience.2006.07.028","volume":"143","author":"J Nemeth","year":"2006","unstructured":"Nemeth J et al (2006) Effect of pituitary adenylate cyclase activating polypeptide-38 on sensory neuropeptide release and neurogenic inflammation in rats and mice. Neuroscience 143(1):223\u2013230","journal-title":"Neuroscience"},{"issue":"1\u20132","key":"1569_CR140","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.pain.2008.10.028","volume":"141","author":"K Sandor","year":"2009","unstructured":"Sandor K et al (2009) Divergent peripheral effects of pituitary adenylate cyclase-activating polypeptide-38 on nociception in rats and mice. Pain 141(1\u20132):143\u2013150","journal-title":"Pain"},{"issue":"5","key":"1569_CR141","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.npep.2010.06.004","volume":"44","author":"K Sandor","year":"2010","unstructured":"Sandor K et al (2010) Impaired nocifensive behaviours and mechanical hyperalgesia, but enhanced thermal allodynia in pituitary adenylate cyclase-activating polypeptide deficient mice. Neuropeptides 44(5):363\u2013371","journal-title":"Neuropeptides"},{"issue":"20","key":"1569_CR142","doi-asserted-by":"publisher","first-page":"8827","DOI":"10.1523\/JNEUROSCI.0439-13.2013","volume":"33","author":"C Robert","year":"2013","unstructured":"Robert C et al (2013) Paraventricular hypothalamic regulation of trigeminovascular mechanisms involved in headaches. J Neurosci 33(20):8827\u20138840","journal-title":"J Neurosci"},{"issue":"308","key":"1569_CR143","doi-asserted-by":"publisher","first-page":"308ra157","DOI":"10.1126\/scitranslmed.aaa7557","volume":"7","author":"S Akerman","year":"2015","unstructured":"Akerman S, Goadsby PJ (2015) Neuronal PAC1 receptors mediate delayed activation and sensitization of trigeminocervical neurons: Relevance to migraine. Sci Transl Med 7(308):308ra157","journal-title":"Sci Transl Med"},{"issue":"21","key":"1569_CR144","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.1523\/JNEUROSCI.2200-20.2021","volume":"41","author":"A Kuburas","year":"2021","unstructured":"Kuburas A et al (2021) PACAP induces light aversion in mice by an inheritable mechanism independent of CGRP. J Neurosci 41(21):4697\u20134715","journal-title":"J Neurosci"},{"key":"1569_CR145","doi-asserted-by":"publisher","unstructured":"Wang M, et al (2021) Investigating migraine-like behavior using light aversion in mice. J Vis Exp (174). https:\/\/doi.org\/10.3791\/62839","DOI":"10.3791\/62839"},{"issue":"1","key":"1569_CR146","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s10194-019-0963-6","volume":"20","author":"D Vuralli","year":"2019","unstructured":"Vuralli D et al (2019) Behavioral and cognitive animal models in headache research. J Headache Pain 20(1):11","journal-title":"J Headache Pain"},{"issue":"1","key":"1569_CR147","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1523\/JNEUROSCI.2967-16.2016","volume":"37","author":"BN Mason","year":"2017","unstructured":"Mason BN et al (2017) Induction of migraine-like photophobic behavior in mice by both peripheral and central CGRP mechanisms. J Neurosci 37(1):204\u2013216","journal-title":"J Neurosci"},{"issue":"14","key":"1569_CR148","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1177\/0333102420949173","volume":"40","author":"BN Mason","year":"2020","unstructured":"Mason BN et al (2020) Vascular actions of peripheral CGRP in migraine-like photophobia in mice. Cephalalgia 40(14):1585\u20131604","journal-title":"Cephalalgia"},{"issue":"9","key":"1569_CR149","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1111\/head.13917","volume":"60","author":"LP Sowers","year":"2020","unstructured":"Sowers LP et al (2020) Stimulation of posterior thalamic nuclei induces photophobic behavior in mice. Headache 60(9):1961\u20131981","journal-title":"Headache"},{"key":"1569_CR150","doi-asserted-by":"publisher","DOI":"10.3389\/fpain.2022.861598","volume":"3","author":"M Wang","year":"2022","unstructured":"Wang M et al (2022) CGRP administration into the cerebellum evokes light aversion, tactile hypersensitivity, and nociceptive squint in mice. Front Pain Res (Lausanne) 3:861598","journal-title":"Front Pain Res (Lausanne)"},{"issue":"27","key":"1569_CR151","doi-asserted-by":"publisher","first-page":"8798","DOI":"10.1523\/JNEUROSCI.1727-09.2009","volume":"29","author":"A Recober","year":"2009","unstructured":"Recober A et al (2009) Role of calcitonin gene-related peptide in light-aversive behavior: implications for migraine. J Neurosci 29(27):8798\u20138804","journal-title":"J Neurosci"},{"issue":"1","key":"1569_CR152","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.neuropharm.2009.07.009","volume":"58","author":"A Recober","year":"2010","unstructured":"Recober A et al (2010) Induction of multiple photophobic behaviors in a transgenic mouse sensitized to CGRP. Neuropharmacology 58(1):156\u2013165","journal-title":"Neuropharmacology"},{"issue":"44","key":"1569_CR153","doi-asserted-by":"publisher","first-page":"15439","DOI":"10.1523\/JNEUROSCI.3265-12.2012","volume":"32","author":"EA Kaiser","year":"2012","unstructured":"Kaiser EA et al (2012) Modulation of CGRP-induced light aversion in wild-type mice by a 5-HT(1B\/D) agonist. J Neurosci 32(44):15439\u201315449","journal-title":"J Neurosci"},{"issue":"1","key":"1569_CR154","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.nbd.2011.10.010","volume":"45","author":"A Markovics","year":"2012","unstructured":"Markovics A et al (2012) Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice. Neurobiol Dis 45(1):633\u2013644","journal-title":"Neurobiol Dis"},{"issue":"11","key":"1569_CR155","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1177\/0333102414523846","volume":"34","author":"DK Bhatt","year":"2014","unstructured":"Bhatt DK et al (2014) PACAP-38 infusion causes sustained vasodilation of the middle meningeal artery in the rat: possible involvement of mast cells. Cephalalgia 34(11):877\u2013886","journal-title":"Cephalalgia"},{"key":"1569_CR156","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fncel.2019.00114","volume":"13","author":"SH Pedersen","year":"2019","unstructured":"Pedersen SH et al (2019) PACAP-38 and PACAP(6\u201338) degranulate rat meningeal mast cells via the orphan MrgB3-receptor. Front Cell Neurosci 13:114","journal-title":"Front Cell Neurosci"},{"key":"1569_CR157","doi-asserted-by":"crossref","unstructured":"Guo Z, et al (2020) Increase in trigeminal ganglion neurons that respond to both CGRP and PACAP in mouse models of chronic migraine and post-traumatic headache. Pain 162(5):1483\u20131499","DOI":"10.1097\/j.pain.0000000000002147"},{"issue":"3","key":"1569_CR158","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004729","volume":"4","author":"KA Aldinger","year":"2009","unstructured":"Aldinger KA et al (2009) Genetic variation and population substructure in outbred CD-1 mice: implications for genome-wide association studies. PLoS ONE 4(3):e4729","journal-title":"PLoS ONE"},{"issue":"1","key":"1569_CR159","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s10194-019-0968-1","volume":"20","author":"F De Logu","year":"2019","unstructured":"De Logu F et al (2019) Migraine-provoking substances evoke periorbital allodynia in mice. J Headache Pain 20(1):18","journal-title":"J Headache Pain"},{"issue":"4","key":"1569_CR160","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1097\/j.pain.0000000000002103","volume":"162","author":"AS Wattiez","year":"2021","unstructured":"Wattiez AS et al (2021) Different forms of traumatic brain injuries cause different tactile hypersensitivity profiles. Pain 162(4):1163\u20131175","journal-title":"Pain"},{"issue":"9","key":"1569_CR161","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.jpain.2009.03.018","volume":"10","author":"B Marquez de Prado","year":"2009","unstructured":"Marquez de Prado B, Hammond DL, Russo AF (2009) Genetic enhancement of calcitonin gene-related Peptide-induced central sensitization to mechanical stimuli in mice. J Pain 10(9):992\u20131000","journal-title":"J Pain"},{"issue":"7","key":"1569_CR162","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1177\/0333102419896539","volume":"40","author":"EI Araya","year":"2020","unstructured":"Araya EI et al (2020) Contribution of intraganglionic CGRP to migraine-like responses in male and female rats. Cephalalgia 40(7):689\u2013700","journal-title":"Cephalalgia"},{"issue":"7","key":"1569_CR163","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1093\/brain\/awac040","volume":"145","author":"C Ernstsen","year":"2022","unstructured":"Ernstsen C et al (2022) The PACAP pathway is independent of CGRP in mouse models of migraine: possible new drug target? Brain 145(7):2450\u20132460","journal-title":"Brain"},{"issue":"14","key":"1569_CR164","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1177\/03331024211038884","volume":"41","author":"SL Christensen","year":"2021","unstructured":"Christensen SL et al (2021) CGRP-dependent signalling pathways involved in mouse models of GTN- cilostazol- and levcromakalim-induced migraine. Cephalalgia 41(14):1413\u20131426","journal-title":"Cephalalgia"},{"issue":"7","key":"1569_CR165","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1177\/0333102420925513","volume":"40","author":"SL Christensen","year":"2020","unstructured":"Christensen SL et al (2020) ATP sensitive potassium (K(ATP)) channel inhibition: A promising new drug target for migraine. Cephalalgia 40(7):650\u2013664","journal-title":"Cephalalgia"},{"issue":"1","key":"1569_CR166","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s10194-022-01523-8","volume":"23","author":"S Guo","year":"2022","unstructured":"Guo S et al (2022) PACAP signaling is not involved in GTN- and levcromakalim-induced hypersensitivity in mouse models of migraine. J Headache Pain 23(1):155","journal-title":"J Headache Pain"},{"key":"1569_CR167","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.bcp.2017.07.005","volume":"142","author":"MJ Woolley","year":"2017","unstructured":"Woolley MJ et al (2017) Receptor activity-modifying protein dependent and independent activation mechanisms in the coupling of calcitonin gene-related peptide and adrenomedullin receptors to Gs. Biochem Pharmacol 142:96\u2013110","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"1569_CR168","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1523\/JNEUROSCI.4542-06.2007","volume":"27","author":"Z Zhang","year":"2007","unstructured":"Zhang Z et al (2007) Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion. J Neurosci 27(10):2693\u20132703","journal-title":"J Neurosci"},{"issue":"10","key":"1569_CR169","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.tips.2010.06.006","volume":"31","author":"CS Walker","year":"2010","unstructured":"Walker CS et al (2010) Regulation of signal transduction by calcitonin gene-related peptide receptors. Trends Pharmacol Sci 31(10):476\u2013483","journal-title":"Trends Pharmacol Sci"},{"issue":"13","key":"1569_CR170","doi-asserted-by":"publisher","first-page":"5310","DOI":"10.1523\/JNEUROSCI.22-13-05310.2002","volume":"22","author":"C Hamelink","year":"2002","unstructured":"Hamelink C et al (2002) Coincident elevation of cAMP and calcium influx by PACAP-27 synergistically regulates vasoactive intestinal polypeptide gene transcription through a novel PKA-independent signaling pathway. J Neurosci 22(13):5310\u20135320","journal-title":"J Neurosci"},{"issue":"1","key":"1569_CR171","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1476-5381.2012.01871.x","volume":"166","author":"AJ Harmar","year":"2012","unstructured":"Harmar AJ et al (2012) Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1. Br J Pharmacol 166(1):4\u201317","journal-title":"Br J Pharmacol"},{"issue":"2","key":"1569_CR172","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3390\/biomedicines10020406","volume":"10","author":"I Langer","year":"2022","unstructured":"Langer I et al (2022) Signal transduction by VIP and PACAP Receptors. Biomedicines 10(2):406","journal-title":"Biomedicines"},{"issue":"49","key":"1569_CR173","doi-asserted-by":"publisher","first-page":"25763","DOI":"10.1074\/jbc.A116.751362","volume":"291","author":"C Weston","year":"2016","unstructured":"Weston C et al (2016) Receptor activity-modifying protein-directed G protein signaling specificity for the calcitonin gene-related peptide family of receptors. J Biol Chem 291(49):25763","journal-title":"J Biol Chem"},{"issue":"3","key":"1569_CR174","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0014-2999(00)00656-7","volume":"407","author":"N Parameswaran","year":"2000","unstructured":"Parameswaran N et al (2000) Desensitization and resensitization of adrenomedullin-sensitive receptor in rat mesangial cells. Eur J Pharmacol 407(3):205\u2013210","journal-title":"Eur J Pharmacol"},{"key":"1569_CR175","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1113\/jphysiol.1992.sp019306","volume":"455","author":"JW Wiley","year":"1992","unstructured":"Wiley JW, Gross RA, MacDonald RL (1992) The peptide CGRP increases a high-threshold Ca2+ current in rat nodose neurones via a pertussis toxin-sensitive pathway. J Physiol 455:367\u2013381","journal-title":"J Physiol"},{"key":"1569_CR176","doi-asserted-by":"crossref","unstructured":"Aiyar N et al (1999) Calcitonin gene-related peptide receptor independently stimulates 3\u2019,5\u2019-cyclic adenosine monophosphate and Ca2+ signaling pathways. Mol Cell Biochem 197(1\u20132):179\u2013185","DOI":"10.1023\/A:1006962221332"},{"issue":"32","key":"1569_CR177","doi-asserted-by":"publisher","first-page":"20168","DOI":"10.1074\/jbc.273.32.20168","volume":"273","author":"H Drissi","year":"1998","unstructured":"Drissi H et al (1998) Activation of phospholipase C-beta1 via Galphaq\/11 during calcium mobilization by calcitonin gene-related peptide. J Biol Chem 273(32):20168\u201320174","journal-title":"J Biol Chem"},{"key":"1569_CR178","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fendo.2013.00055","volume":"4","author":"J Blechman","year":"2013","unstructured":"Blechman J, Levkowitz G (2013) Alternative splicing of the pituitary adenylate cyclase-activating polypeptide receptor PAC1: mechanisms of fine tuning of brain activity. Front Endocrinol (Lausanne) 4:55","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1569_CR179","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1021\/acsptsci.8b00002","volume":"1","author":"RL Bower","year":"2018","unstructured":"Bower RL et al (2018) Molecular signature for receptor engagement in the metabolic peptide hormone amylin. ACS Pharmacol Transl Sci 1(1):32\u201349","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"2","key":"1569_CR180","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1021\/acsptsci.9b00083","volume":"3","author":"ML Garelja","year":"2020","unstructured":"Garelja ML et al (2020) Molecular mechanisms of class B GPCR activation: insights from adrenomedullin receptors. ACS Pharmacol Transl Sci 3(2):246\u2013262","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"3","key":"1569_CR181","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/bph.15700","volume":"179","author":"Z Tasma","year":"2022","unstructured":"Tasma Z et al (2022) Characterisation of agonist signalling profiles and agonist-dependent antagonism at PACAP-responsive receptors: Implications for drug discovery. Br J Pharmacol 179(3):435\u2013453","journal-title":"Br J Pharmacol"},{"issue":"1","key":"1569_CR182","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s10194-018-0848-0","volume":"19","author":"K Messlinger","year":"2018","unstructured":"Messlinger K (2018) The big CGRP flood - sources, sinks and signalling sites in the trigeminovascular system. J Headache Pain 19(1):22","journal-title":"J Headache Pain"},{"issue":"1","key":"1569_CR183","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bph.14075","volume":"175","author":"DL Hay","year":"2018","unstructured":"Hay DL et al (2018) Update on the pharmacology of calcitonin\/CGRP family of peptides: IUPHAR review 25. Br J Pharmacol 175(1):3\u201317","journal-title":"Br J Pharmacol"},{"issue":"3","key":"1569_CR184","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1177\/0333102417691762","volume":"38","author":"CS Walker","year":"2018","unstructured":"Walker CS et al (2018) CGRP receptor antagonist activity of olcegepant depends on the signalling pathway measured. Cephalalgia 38(3):437\u2013451","journal-title":"Cephalalgia"},{"issue":"8","key":"1569_CR185","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1097\/j.pain.0000000000002537","volume":"163","author":"BJ Rea","year":"2022","unstructured":"Rea BJ et al (2022) Automated detection of squint as a sensitive assay of sex-dependent calcitonin gene-related peptide and amylin-induced pain in mice. Pain 163(8):1511\u20131519","journal-title":"Pain"},{"issue":"1","key":"1569_CR186","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/0006-291X(89)91757-9","volume":"164","author":"A Miyata","year":"1989","unstructured":"Miyata A et al (1989) Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 164(1):567\u2013574","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"1569_CR187","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.pharmthera.2008.11.006","volume":"121","author":"L Dickson","year":"2009","unstructured":"Dickson L, Finlayson K (2009) VPAC and PAC receptors: From ligands to function. Pharmacol Ther 121(3):294\u2013316","journal-title":"Pharmacol Ther"},{"issue":"6","key":"1569_CR188","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1111\/bph.12541","volume":"171","author":"CS Walker","year":"2014","unstructured":"Walker CS, Sundrum T, Hay DL (2014) PACAP receptor pharmacology and agonist bias: analysis in primary neurons and glia from the trigeminal ganglia and transfected cells. Br J Pharmacol 171(6):1521\u20131533","journal-title":"Br J Pharmacol"},{"issue":"8","key":"1569_CR189","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1096\/fj.11-203042","volume":"26","author":"AC Emery","year":"2012","unstructured":"Emery AC, Eiden LE (2012) Signaling through the neuropeptide GPCR PAC(1) induces neuritogenesis via a single linear cAMP- and ERK-dependent pathway using a novel cAMP sensor. FASEB J 26(8):3199\u20133211","journal-title":"FASEB J"},{"issue":"6","key":"1569_CR190","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1124\/mol.107.044792","volume":"73","author":"A Ravni","year":"2008","unstructured":"Ravni A et al (2008) A cAMP-dependent, protein kinase A-independent signaling pathway mediating neuritogenesis through Egr1 in PC12 cells. Mol Pharmacol 73(6):1688\u20131708","journal-title":"Mol Pharmacol"},{"issue":"2","key":"1569_CR191","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1152\/physrev.00025.2017","volume":"98","author":"WG Robichaux 3rd","year":"2018","unstructured":"Robichaux WG 3rd, Cheng X (2018) Intracellular cAMP sensor EPAC: physiology, pathophysiology, and therapeutics development. Physiol Rev 98(2):919\u20131053","journal-title":"Physiol Rev"},{"issue":"6","key":"1569_CR192","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S0962-8924(02)02294-8","volume":"12","author":"PJ Stork","year":"2002","unstructured":"Stork PJ, Schmitt JM (2002) Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol 12(6):258\u2013266","journal-title":"Trends Cell Biol"},{"issue":"8","key":"1569_CR193","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1007\/s12031-021-01821-x","volume":"71","author":"V May","year":"2021","unstructured":"May V et al (2021) PAC1 receptor internalization and endosomal MEK\/ERK activation is essential for PACAP-mediated neuronal excitability. J Mol Neurosci 71(8):1536\u20131542","journal-title":"J Mol Neurosci"},{"issue":"4","key":"1569_CR194","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1165\/rcmb.2012-0354OC","volume":"48","author":"AB Hartopo","year":"2013","unstructured":"Hartopo AB et al (2013) Endothelin-converting enzyme-1 gene ablation attenuates pulmonary fibrosis via CGRP-cAMP\/EPAC1 pathway. Am J Respir Cell Mol Biol 48(4):465\u2013476","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"1569_CR195","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086367","volume":"9","author":"N Mikami","year":"2014","unstructured":"Mikami N et al (2014) Calcitonin gene-related peptide regulates type IV hypersensitivity through dendritic cell functions. PLoS ONE 9(1):e86367","journal-title":"PLoS ONE"},{"issue":"1","key":"1569_CR196","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s42003-021-02293-w","volume":"4","author":"AJ Clark","year":"2021","unstructured":"Clark AJ et al (2021) CGRP, adrenomedullin and adrenomedullin 2 display endogenous GPCR agonist bias in primary human cardiovascular cells. Commun Biol 4(1):776","journal-title":"Commun Biol"},{"issue":"26","key":"1569_CR197","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.1523\/JNEUROSCI.0285-05.2005","volume":"25","author":"TB Hucho","year":"2005","unstructured":"Hucho TB, Dina OA, Levine JD (2005) Epac mediates a cAMP-to-PKC signaling in inflammatory pain: an isolectin B4(+) neuron-specific mechanism. J Neurosci 25(26):6119\u20136126","journal-title":"J Neurosci"},{"issue":"2","key":"1569_CR198","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1021\/acsptsci.9b00089","volume":"3","author":"JJ Gingell","year":"2020","unstructured":"Gingell JJ et al (2020) Distinct patterns of internalization of different calcitonin gene-related peptide receptors. ACS Pharmacol Transl Sci 3(2):296\u2013304","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"5","key":"1569_CR199","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1177\/0333102420983282","volume":"41","author":"M Bhakta","year":"2021","unstructured":"Bhakta M et al (2021) Migraine therapeutics differentially modulate the CGRP pathway. Cephalalgia 41(5):499\u2013514","journal-title":"Cephalalgia"},{"key":"1569_CR200","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.bcp.2017.12.016","volume":"148","author":"E Dal Maso","year":"2018","unstructured":"Dal Maso E et al (2018) Characterization of signalling and regulation of common calcitonin receptor splice variants and polymorphisms. Biochem Pharmacol 148:111\u2013129","journal-title":"Biochem Pharmacol"},{"issue":"46","key":"1569_CR201","doi-asserted-by":"publisher","first-page":"12309","DOI":"10.1073\/pnas.1706656114","volume":"114","author":"RE Yarwood","year":"2017","unstructured":"Yarwood RE et al (2017) Endosomal signaling of the receptor for calcitonin gene-related peptide mediates pain transmission. Proc Natl Acad Sci U S A 114(46):12309\u201312314","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1569_CR202","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/s41467-022-28204-z","volume":"13","author":"F De Logu","year":"2022","unstructured":"De Logu F et al (2022) Schwann cell endosome CGRP signals elicit periorbital mechanical allodynia in mice. Nat Commun 13(1):646","journal-title":"Nat Commun"},{"key":"1569_CR203","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fendo.2012.00129","volume":"3","author":"I Langer","year":"2012","unstructured":"Langer I (2012) Mechanisms involved in VPAC receptors activation and regulation: lessons from pharmacological and mutagenesis studies. Front Endocrinol (Lausanne) 3:129","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"1569_CR204","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1111\/j.1468-2982.2006.01149.x","volume":"26","author":"JM Hansen","year":"2006","unstructured":"Hansen JM et al (2006) Vasoactive intestinal polypeptide evokes only a minimal headache in healthy volunteers. Cephalalgia 26(8):992\u20131003","journal-title":"Cephalalgia"},{"issue":"1","key":"1569_CR205","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1177\/0333102420970889","volume":"41","author":"M Ashina","year":"2021","unstructured":"Ashina M et al (2021) A phase 2, randomized, double-blind, placebo-controlled trial of AMG 301, a pituitary adenylate cyclase-activating polypeptide PAC1 receptor monoclonal antibody for migraine prevention. Cephalalgia 41(1):33\u201344","journal-title":"Cephalalgia"},{"issue":"4","key":"1569_CR206","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.cell.2019.10.010","volume":"179","author":"SR Foster","year":"2019","unstructured":"Foster SR et al (2019) Discovery of human signaling systems: pairing peptides to G protein-coupled receptors. Cell 179(4):895-908.e21","journal-title":"Cell"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-023-01569-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-023-01569-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-023-01569-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T23:03:45Z","timestamp":1702163025000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-023-01569-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,3]]},"references-count":206,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1569"],"URL":"https:\/\/doi.org\/10.1186\/s10194-023-01569-2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742720300.793599815","asserted-by":"object"}]},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,3]]},"assertion":[{"value":"20 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AFR is a consultant for Lundbeck, Abbvie, Eli Lilly, and Schedule One Therapeutics. AK declares no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}